We are live on
!
Find out more
JAFL
Jay A. Fishman Ltd Portfolio holdings
AUM
$1.12B
1-Year Est. Return
32.75%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+32.75%
3 Year Est. Return
+106.85%
5 Year Est. Return
+144.56%
10 Year Est. Return
+606.28%
AUM
$530M
AUM Growth
+$40M
(+8.1%)
Cap. Flow
+$1.43M
Cap. Flow
% of AUM
0.27%
Top 10 Holdings %
Top 10 Hldgs %
57%
Holding
96
New
3
Increased
30
Reduced
33
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$6.9M |
| 2 |
Lennar Class A
LEN
|
+$6.32M |
| 3 |
Home Depot
HD
|
+$2.34M |
| 4 |
General Motors
GM
|
+$2.29M |
| 5 |
Amazon
AMZN
|
+$1.69M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$10.1M |
| 2 |
CELG
Celgene Corp
CELG
|
+$3.6M |
| 3 |
Starbucks
SBUX
|
+$2.75M |
| 4 |
Medtronic
MDT
|
+$826K |
| 5 |
CVS Health
CVS
|
+$767K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.39% |
| 2 | Technology | 17.57% |
| 3 | Healthcare | 15.13% |
| 4 | Financials | 14.11% |
| 5 | Consumer Discretionary | 12.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Vanguard Total Stock Market ETF
VTI
$655B
| $343K | 0.06% |
2,500
| – | – |
|
77
iShares Biotechnology ETF
IBB
$9.44B
| $314K | 0.06% |
2,940
+720
| +32% | +$77K |
|
|
FISV
78
Fiserv Inc
FISV
$27.9B
| $274K | 0.05% |
4,180
| – | – |
|
79
Union Pacific
UNP
$178B
| $268K | 0.05% |
2,000
| – | – |
|
80
WEC Energy
WEC
$37.1B
| $266K | 0.05% |
4,000
| – | – |
|
81
Marathon Petroleum
MPC
$91.2B
| $264K | 0.05% |
4,000
| – | – |
|
82
Ferrari
RACE
$66.8B
| $241K | 0.05% |
2,300
| – | – |
|
83
Vanguard Large-Cap ETF
VV
$51.9B
| $240K | 0.05% |
+1,959
| New | +$234K |
|
84
iShares Russell Mid-Cap ETF
IWR
$56.1B
| $239K | 0.05% |
4,600
| – | – |
|
85
MSCI
MSCI
$41.5B
| $234K | 0.04% |
1,850
-25
| -1% | -$3.12K |
|
86
Ulta Beauty
ULTA
$20.7B
| $224K | 0.04% |
1,000
-100
| -9% | -$21.2K |
|
87
Suncor Energy
SU
$75.6B
| $202K | 0.04% |
+5,500
| New | +$191K |
|
88
Huntington Bancshares
HBAN
$34.7B
| $183K | 0.03% |
12,600
| – | – |
|
|
ONIT
89
Onity Group
ONIT
$336M
| $62.6K | 0.01% |
1,333
| – | – |
|
|
ELI
90
DELISTED
ELITE PHARMACEUTICAL
ELI
| $5.52K | ﹤0.01% |
60,000
| – | – |
|
91
CSX Corp
CSX
$96B
| – | – |
-34,197
| Closed | -$619K |
|
92
HCA Healthcare
HCA
$86.4B
| – | – |
-5,625
| Closed | -$448K |
|
|
93
Medtronic
MDT
$108B
| – | – |
-10,621
| Closed | -$826K |
|
|
CELG
94
DELISTED
Celgene Corp
CELG
| – | – |
-24,717
| Closed | -$3.6M |
|
Similar funds
SL
PTC
CT
C
CNC
MTCM
EC
AIM
Jay A. Fishman Ltd's Q4 2017 Portfolio in Review
As of Q4 2017, Jay A. Fishman Ltd held 96 positions worth $530M, up 8.1% from $490M the previous quarter. Its ten largest holdings account for 57% of the portfolio.
Jay A. Fishman Ltd's Q4 2017 filing shows 3 new, 30 increased, 33 reduced and 6 closed positions. Its largest new stake was Ford: 42,861 shares worth $535K. The largest sale was Allergan plc, an estimated $10.1M.
By sector, the portfolio is most concentrated in Industrials at 19% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.
- Jay A. Fishman Ltd's largest Q4 2017 buy was Ford: 42,861 shares worth $535K.
- Jay A. Fishman Ltd added most to Intel in Q4 2017, an estimated $6.9M increase.
- Jay A. Fishman Ltd's biggest Q4 2017 reduction was Allergan plc, cutting an estimated $10.1M.
- Jay A. Fishman Ltd fully exited Celgene Corp in Q4 2017, selling an estimated $3.6M.
- Jay A. Fishman Ltd's ten largest holdings make up 57% of its $530M portfolio in Q4 2017.
- Jay A. Fishman Ltd opened 3 new positions and closed 6 in Q4 2017.
- Jay A. Fishman Ltd's portfolio value rose 8.1% quarter-over-quarter to $530M.
Based on Jay A. Fishman Ltd's 13F filing for Q4 2017, filed 5 Feb 2018.